Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Rank in Stocks #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Share Price
$1.51
Last synced: 2024-08-26
Market Cap
$1.12M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Agile Therapeutics, Inc. (AGRX)

Category

Earnings for Agile Therapeutics, Inc. (AGRX)
Earnings in Jun 2024 TTM: $-15.86M
According to Agile Therapeutics, Inc. latest financial reports the company's current earnings are $-15.86M. In 2022 the company made an earning of $-30.09M, an increase over its 2021 earnings that were of $-74.89M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Agile Therapeutics, Inc. from 2012 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-15.86M 9.62%
2023 $-14.47M -51.92%
2022 $-30.09M -59.83%
2021 $-74.89M 44.44%
2020 $-51.85M 178.69%
2019 $-18.61M -8.15%
2018 $-20.26M -28.43%
2017 $-28.30M -11.04%
2016 $-31.82M -12.37%
2015 $-36.31M 84.02%
2014 $-19.73M 37.77%
2013 $-14.32M -38.43%
2012 $-23.26M 0.00%
Earnings for similar companies or competitors